Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Idexx Laboratories (NQ: IDXX )

480.34 -13.92 (-2.82%)
Streaming Delayed Price Updated: 10:55 AM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Idexx Laboratories

< Previous 1 2 3 4 5 6 7 Next >
IDEXX Laboratories Stock Earns IBD Stock Rating Upgrade
On Wednesday, IDEXX Laboratories now stock clears the 80-plus Relative Strength Rating threshold, with a jump from 79 to 83. 
Via Investor's Business Daily
PROCEPT BioRobotics Stock Scores Rising Relative Strength
The Relative Strength (RS) Rating for PROCEPT BioRobotics stock headed into a new percentile Tuesday, as it got a lift from 70 to 77. 
Via Investor's Business Daily
IDEXX Laboratories Inc. (NASDAQ: IDXX) is a Leading Gainer in Monday Morning Trading
Via Investor Brand Network
SAIC Reports Q3 Results, Joins Uber, Wallbox And Other Big Stocks Moving Higher On Monday
U.S. stocks traded lower, with the Dow Jones index falling more than 100 points on Monday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Here's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today
Via Benzinga
Here's How Much $100 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today
Via Benzinga
How Is The Market Feeling About IDEXX Laboratories?
Via Benzinga
5 Analysts Have This to Say About IDEXX Laboratories
Via Benzinga
Is There An Opportunity To Buy IDEXX Labs, The Animal Diagnostics-Focused Firm Stock After Q3 Performance? Analyst Answers
IDEXX Laboratories Inc (NASDAQ: IDXX) reported Q3 FY23 sales of $915.53 million, missing the consensus of $926.76 million 
Via Benzinga
IDEXX Laboratories Announces Third Quarter Results
From IDEXX Laboratories, Inc.
Via Business Wire
IDEXX Laboratories's Earnings: A Preview
Via Benzinga
This Is What Whales Are Betting On IDEXX Laboratories
Via Benzinga
IDEXX Laboratories to Release 2023 Third Quarter Financial Results
From IDEXX Laboratories, Inc.
Via Business Wire
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,700 Today
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today
Via Benzinga
How Is The Market Feeling About IDEXX Laboratories?
Via Benzinga
IBD's 100 Best ESG Companies For 2023
The companies on our list combine high sustainability scores and top stock ratings. 
Via Investor's Business Daily
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
Via Benzinga
Why IDEXX LABORATORIES INC (NASDAQ:IDXX) qualifies as a quality stock.
Reasonable growth and debt and a high ROIC for IDEXX LABORATORIES INC (NASDAQ:IDXX). 
Via Chartmill
How Is The Market Feeling About IDEXX Laboratories?
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Via Benzinga
3 Stocks Ready to Rocket on These Global Mega Trends
The best stocks to buy right now aren't focused on small, short-term themes. They are companies poised to rocket on global mega trends. 
Via InvestorPlace
IDEXX Labs In The Hot Seat: Analyst Forewarns Dwindling Vet Visits Amid Macro Headwinds Ahead
Stifel analyst Jonathan D. 
Via Benzinga
Here's How Much $1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today
Via Benzinga
Peering Into IDEXX Laboratories's Recent Short Interest
Via Benzinga
3 Top Healthcare Stocks to Buy for August
Shares of Humana, Vertex Pharmaceuticals, and Idexx Laboratories have all increased by at least 20% so far this year. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023
Via Benzinga
Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review
Amazon, ELF and CAT were earnings winners, but there were big losers too. 
Via Investor's Business Daily
IDEXX Laboratories' Q2 Earnings Top Estimates, Analyst Maintain Outperform Citing Resilient Animal Health Market
IDEXX Laboratories Inc (NASDAQ: IDXX) reported Q2 FY23 sales of $943.63 million, beating the consensus of $927.84 million 
Via Benzinga
IDEXX Laboratories Announces Second Quarter Results
From IDEXX Laboratories, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.